Publications by authors named "M V Maciosek"
Article Synopsis
- EMR data offers valuable opportunities for population health research, but missing patient information can hinder its use for risk modeling.
- This study introduces a sequential hot-deck imputation (HDI) method to effectively handle missing cardiometabolic measures from EMR data in a sample of over half a million patients.
- Results show that sequential HDI maintains the distribution of variables and risk scores accurately, making it a viable solution for managing multivariate missing data in population health studies.
Introduction: This study quantifies the impacts of strengthening 2 tobacco control policies in "Tobacco Nation," a region of the United States (U.S.) with persistently higher smoking rates and weaker tobacco control policies than the rest of the US, despite high levels of support for tobacco control policies.
View Article and Find Full Text PDFIn the past 2 decades, the demand for information on health economics research to guide health care decision making has substantially increased. Studies have provided evidence that eliminating or reducing tobacco use; eating a healthy diet, including fruit and vegetables; being physically active; reducing alcohol consumption; avoiding ultraviolet radiation; and minimizing exposure to environmental and occupational carcinogenic agents should substantially reduce cancer incidence in the population. The benefits of these primary prevention measures in reducing cancer incidence are not instantaneous.
View Article and Find Full Text PDFImportance: The US Preventive Services Task Force (USPSTF) is updating its 2016 recommendation on the use of aspirin for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC).
Objective: To provide updated model-based estimates of the net balance in benefits and harms from routine use of low-dose aspirin for primary prevention.
Design, Setting, And Participants: Microsimulation modeling was used to estimate long-term benefits and harms for hypothetical US cohorts of men and women aged 40 to 79 years with up to 20% 10-year risk for an atherosclerotic CVD event and without prior history of CVD or elevated bleeding risks.